142 related articles for article (PubMed ID: 1591088)
1. A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma.
Byrne J; Horgan PG; England S; Callaghan J; Given HF
Eur J Cancer; 1992; 28(2-3):658-60. PubMed ID: 1591088
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the usefulness of primary tumour expression of MCA and CA15-3 as prognostic indicators in breast carcinoma.
Byrne J; Horgan PG; England S; Callaghan J; Given HF
Eur J Surg Oncol; 1992 Jun; 18(3):230-4. PubMed ID: 1607033
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases.
Elson CE; Kufe D; Johnston WW
Anal Quant Cytol Histol; 1993 Jun; 15(3):171-8. PubMed ID: 7688511
[TBL] [Abstract][Full Text] [Related]
4. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
[TBL] [Abstract][Full Text] [Related]
5. MCA performance in preoperative breast cancer patients.
Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of lymph node micrometastases from breast cancer.
Tsuchiya A; Sugano K; Kimijima I; Abe R
Acta Oncol; 1996; 35(4):425-8. PubMed ID: 8695155
[TBL] [Abstract][Full Text] [Related]
7. A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer.
Bombardieri E; Gion M; Mione R; Dittadi R; Bruscagnin G; Buraggi G
Cancer; 1989 Feb; 63(3):490-5. PubMed ID: 2643453
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of micrometastases in axillary lymph nodes in breast carcinoma].
Stosiek P; Gerber B; Kasper M
Pathologe; 1996 Nov; 17(6):433-9. PubMed ID: 9082364
[TBL] [Abstract][Full Text] [Related]
9. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
Tumori; 1990 Aug; 76(4):360-4. PubMed ID: 2399565
[TBL] [Abstract][Full Text] [Related]
10. The immunocytochemical detection of axillary micrometastases in breast cancer.
Wells CA; Heryet A; Brochier J; Gatter KC; Mason DY
Br J Cancer; 1984 Aug; 50(2):193-7. PubMed ID: 6380553
[TBL] [Abstract][Full Text] [Related]
11. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.
Byrne J; Waldron R; McAvinchey D; Dervan P
Eur J Surg Oncol; 1987 Oct; 13(5):409-11. PubMed ID: 3311817
[TBL] [Abstract][Full Text] [Related]
12. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.
Trojani M; de Mascarel I; Bonichon F; Coindre JM; Delsol G
Br J Cancer; 1987 Mar; 55(3):303-6. PubMed ID: 3552017
[TBL] [Abstract][Full Text] [Related]
13. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer.
Raymond WA; Leong AS
Pathology; 1989 Jan; 21(1):11-5. PubMed ID: 2474791
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
16. The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
Gion M; Mione R; Nascimben O; Valsecchi M; Gatti C; Leon A; Bruscagnin G
Br J Cancer; 1991 May; 63(5):809-13. PubMed ID: 2039707
[TBL] [Abstract][Full Text] [Related]
17. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
19. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
[TBL] [Abstract][Full Text] [Related]
20. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
Nuti M; Castagna M; Squartini F
Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
